[go: up one dir, main page]

MD3555G2 - Method of hepatic encephalopathy treatment - Google Patents

Method of hepatic encephalopathy treatment

Info

Publication number
MD3555G2
MD3555G2 MDA20070297A MD20070297A MD3555G2 MD 3555 G2 MD3555 G2 MD 3555G2 MD A20070297 A MDA20070297 A MD A20070297A MD 20070297 A MD20070297 A MD 20070297A MD 3555 G2 MD3555 G2 MD 3555G2
Authority
MD
Moldova
Prior art keywords
hepatic encephalopathy
encephalopathy treatment
solution
treatment
desintoxication
Prior art date
Application number
MDA20070297A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3555F1 (en
Inventor
Влада-Татьяна ДУМБРАВА
Людмила КОНДРАЦКИЙ
Валериу РУДИК
Валериу ИСТРАТИ
Юлианна ЛУПАШКО
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20070297A priority Critical patent/MD3555G2/en
Publication of MD3555F1 publication Critical patent/MD3555F1/en
Publication of MD3555G2 publication Critical patent/MD3555G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to the internal diseases and neurology.The method of hepatic encephalopathy treatment includes prescription of diet, sanation of intestine with a buffer solution of sodium acetate or lactulose and with antibiotics of wide spectrum, therapy for ammonia desintoxication, for correction of the acid-base balance. Additionally, it is intramuscularly administered 0.5% BioR solution, for 1,0 ml, daily, during 10…12 days.
MDA20070297A 2007-11-01 2007-11-01 Method of hepatic encephalopathy treatment MD3555G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20070297A MD3555G2 (en) 2007-11-01 2007-11-01 Method of hepatic encephalopathy treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20070297A MD3555G2 (en) 2007-11-01 2007-11-01 Method of hepatic encephalopathy treatment

Publications (2)

Publication Number Publication Date
MD3555F1 MD3555F1 (en) 2008-04-30
MD3555G2 true MD3555G2 (en) 2008-11-30

Family

ID=39365454

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20070297A MD3555G2 (en) 2007-11-01 2007-11-01 Method of hepatic encephalopathy treatment

Country Status (1)

Country Link
MD (1) MD3555G2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2354G2 (en) * 2003-07-29 2004-07-31 Борис ПЫРГАРЬ Method of treatment of the hepatic encephalopathy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2354G2 (en) * 2003-07-29 2004-07-31 Борис ПЫРГАРЬ Method of treatment of the hepatic encephalopathy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Топорков А. С., Комплексаня терапия печеночной энцефалопатии. Consilium medicum. Приложение. Хирургия. Том 07, № 2, 2005, găsit Internet, < http://www.consilium-medicum.com/media/article/1692> *

Also Published As

Publication number Publication date
MD3555F1 (en) 2008-04-30

Similar Documents

Publication Publication Date Title
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
MX2009003372A (en) Non-mucoadhesive film dosage forms.
UA104320C2 (en) Pharmaceutical composition based on mitochondria-targeted antioxidants for use in medical and veterinary ophthalmology
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington&#39;s disease
EA200702522A1 (en) SYSTEM OF DELIVERY OF MEDICINES IN THE CAVITY OF THE MOUTH AND METHODS OF ITS APPLICATION
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
MX2009013989A (en) Combination therapy for depression.
MX2010013766A (en) Rasagiline for parkinson&#39;s disease modification.
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson&#39;s disease
UA98136C2 (en) Use of aclidinium for the treatment of respiratory diseases
UA107578C2 (en) COMBINED DIABETES THERAPY
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
MX2009011900A (en) Diabetic wound healing.
HK1124863A1 (en) Inhibitors of sodium glucose co-transporter 2 and methods of their use
UA103756C2 (en) Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
HK1106246A1 (en) S-tenatoprazole monohydrated sodium salt and the use thereof in therapy s-
MD3555G2 (en) Method of hepatic encephalopathy treatment
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA200601514A1 (en) DERIVATIVES OF PIPERASINUM URINE FOR THE TREATMENT OF ENDOMETRIOSIS
RU2008107113A (en) MEANS AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER&#39;S DISEASE
RU2009123045A (en) METHOD FOR REDUCING THE NEGATIVE INFLUENCE OF NOISE ON THE ANTIOXIDANT HUMAN ORGANISM SYSTEM
MD3446F1 (en) Method of HIV infection treatment
UA89336U (en) Method for correcting postoperative cognitive dysfunctions
MD3503G2 (en) Method of pain syndrome relief
UA85118C2 (en) Method for treatment of vestibulovaginitis in cows

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees